ArticleBMC infectious diseases2025
Simultaneous circulation of all four dengue virus serotypes during a single outbreak in Kassala, Eastern Sudan 2023.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Viral and host determinants of arboviral disease severity in African populations: A systematic review with meta-analysis.PLoS neglected tropical diseases · 2026Pooled it
- Article
- Dysregulated T cell responses and inflammatory cytokine profiles in patients with acute chikungunya fever: a study from Guangdong, 2025.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue is one of the major health problems worldwide and Sudan is one of thecountries with high burden of the disease especially the eastern part which is endemic fordengue. This study aimed to identify the circulating dengue serotypes during the outbreak of thedisease in Kassala 2023.
methodsWe prospectively enrolled 548 febrile patients suspected of dengue infection who visitedKassala teaching hospital between September 2023 and February 2024.Diagnostic confirmation was achieved through rapid tests (NS1 antigen, IgM, and IgG), and reverse transcription polymerase chain reaction (RT-PCR) was employed to identify various dengue serotypes.
resultsOf the 548 febrile patients, dengue was confirmed in 50.4% (276/548) using rapid diagnostic tests. Among these, the NS1 antigen was positive in 70.7% (195/276), while IgM was detected in 0.4% (1/276). Seropositivity for both NS1 antigen and IgM was observed in 27.5% (76/276), with IgM and IgG co-detected in 1.4% (4/276). Serotype differentiation via RT-PCR revealed that DENV-III was the most prevalent at 50% (133/266), followed by DENV-II at 39.8% (106/266). DENV-IV accounted for 3% (8/266), and a co-detection of DENV-II and DENV-III in same sample was observed in 4.9% (13/266) as well as serotypes I and III together constituted 2.4% (6/266). The patient demographic included predominantly males (56.8%, 151/276), laborers (45.7%, 126/276), individuals with secondary education (41.7%, 115/276), and urban residents (83.7%, 231/276). The mean age of patients was 32.1 ± 12.9 years. The most common symptoms included fever (100%), headache (95.7%), back pain (91.7%), joint pain (87.7%), sweating (84%), nausea (84.8%), chills (83%), and hemorrhagic manifestations (15.6%). Statistical analysis indicated significant associations between male gender (P = 0.014), headache (P = 0.040) and chills (P = 0.010) with dengue serotypes III.
conclusionThis study highlights the high prevalence of dengue infection among febrile patients at Kassala Teaching Hospital, with all four dengue virus serotypes being circulated duringthe outbreakof the disease 2023. Further large-scale studies, including genomic analyses of dengue, are essential to elucidate the relationships among dengue serotypes, genotypes, and clinical manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.